CompletedNot Applicable

Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

Japan647 participantsStarted 2012-04

Plain-language summary

The purpose of this study is to collect following data in patients given Nexium capsule (Nexium) in usual post-marketing use as the maintenance therapy for repeatedly recurring/relapsing reflux oesophagitis.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with repeatedly recurring/relapsing reflux oesophagitis who will be given Nexium for the first time as a maintenance therapy. Exclusion Criteria: * Patients having reflux oesophagitis when Nexium is started (Grade A, Grade B, Grade C or Grade D of Los Angeles Classification (Hoshihara's modification) on endoscopy) * Patients having previous history of maintenance therapy for repeatedly recurring/ relapsing reflux oesophagitis

What they're measuring

Number of Adverse Drug Reactions

Timeframe: 6 Month

Trial details

NCT IDNCT01562639

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Repeatedly Recurring Esophagitis trials